Judice Kevin 4
4 · DICE Therapeutics, Inc. · Filed May 5, 2023
Insider Transaction Report
Form 4
Judice Kevin
DirectorCEO
Transactions
- Sale
Common Stock
2023-05-03$36.50/sh−13,698$499,977→ 799,685 total
Footnotes (1)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 28, 2022.